Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche's dealmakers at pRED will continue their global shopping spree in 2014
Fierce Biotech
Thu, 01/16/14 - 09:23 am
Tags:
Roche, pRED, R&D
Completing a U-turn on RNA, Roche's resurgent pRED strikes deal with Santaris
Fierce Biotech
Sat, 01/11/14 - 08:06 am
Tags:
RNA, Roche, Santaris, pRED, R&D
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
Tags:
M&A, biotech, generics, Merck, Bristol-Myers Squibb, General Electric, Gilead Sciences, Thermo Fisher, Forest Labs, FDA, Acorda Therapeutics, Pfizer, JNJ, Roche, Pharmacyclics
Roche, Teva and AstraZeneca are all said to be in the mix to buy Celltrion
Fierce Pharma
Wed, 01/8/14 - 11:11 am
Tags:
Roche, Teva, AstraZeneca, biosimilars, M&A, Celltrion, South Korea
Is Tamiflu Worth It? Britain Reconsiders a Best-Selling Flu Remedy
Bloomberg/Businessweek
Fri, 01/3/14 - 04:06 pm
Tags:
Tamiflu, Roche, Great Britain
Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
Seeking Alpha
Fri, 01/3/14 - 11:56 am
Tags:
Pharmacyclics, Imbruvica, JNJ, Roche, Celgene, Gilead Sciences, mantle cell lymphoma
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Thu, 01/2/14 - 09:35 am
Tags:
Bristol-Myers Squibb, Roche, brain cancer, CytRx, Celldex Therapeutics, ImmunoCellular Therapeutics, Northwest Biotherapeutics, glioblastoma multiforme, nivolumab, Yervoy
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Tags:
Bristol-Myers Squibb, Celgene, Gilead Sciences, Biogen Idec, AbbVie, Roche, JNJ, GSK, Amgen, Novo Nordisk, Pfizer, Novartis, Merck, Sanofi, AstraZeneca, Eli Lilly
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
Fri, 12/27/13 - 01:08 pm
Tags:
cancer, Roche, Infinity Pharmaceuticals, Inovio, Immunogen, Gilead Sciences, immunotherapy, antibody-drug conjugate
Roche: Some Companies Rebuild, This One Reloads
Motley Fool
Fri, 12/27/13 - 12:18 pm
Tags:
Roche
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Tags:
Inovio, Pharma CEOs, PDL-1, immunotherapy, Joseph Kim, Bristol-Myers Squibb, Roche, Dendreon, GSK, ImmunoCellular Therapeutics, Merck, Northwest Biotherapeutics
Roche Share Discount Widens on Bet Novartis to Sell Stake
Bloomberg
Tue, 12/17/13 - 08:56 am
Tags:
Roche, Novartis
Why did Roche kill off its Alzheimer's program for the BACE inhibitor RG7129?
Fierce Biotech
Fri, 12/13/13 - 10:51 am
Tags:
Roche, BACE inhibitors, Alzheimer's disease, RG7129
Avastin Misses Mark Again in Breast Cancer
MedPage Today
Thu, 12/12/13 - 11:15 am
Tags:
Avastin, Roche, HER-2 postive breast cancer
Roche in deal worth up to $600 mln for Prothena Parkinson's drug
Yahoo/Reuters
Thu, 12/12/13 - 11:13 am
Tags:
Roche, Prothena, Parkinson's Disease, PRX-022
J&J, Roche, Novartis tout key cancer-drug data at ASH
Fierce Pharma
Mon, 12/9/13 - 10:12 am
Tags:
JNJ, Roche, Novartis, Imbruvica, Tasigna, CLL, Gazyva
New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential
Bloomberg
Mon, 12/9/13 - 08:38 am
Tags:
Gilead Sciences, Roche, Pharmacyclics, CLL, chronic lymphocytic leukemia
Breast Cancer Drug Data Boosts Puma Biotechnology
Investors.com
Thu, 12/5/13 - 12:01 pm
Tags:
Puma Biotechnology, breast cancer, neratinib, Taxol, Bristol-Myers Squibb, Roche, Herceptin
Ditching Big Drugmakers for Biotech Brings Leukemia Boon
Bloomberg
Thu, 12/5/13 - 08:26 am
Tags:
chronic lymphocytic leukemia, Gilead, Pharmacyclics, CLL, Roche
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Tags:
Bristol-Myers Squibb, GSK, JNJ, Ophthotech, Novartis, Regeneron, Roche, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.